Drug-induced Parkinson syndrome: 10 years of drug vigilance
Llau, M.E.; Nguyen, L.; Senard, J.M.; Rascol, O.; Montastruc, J.L.
Therapie 49(5): 459-460
1994
ISSN/ISBN: 0040-5957 PMID: 7855765 Document Number: 431994
Document emailed within 1 workday
Related Documents
Zakrzewska, F. 1970: Hoffmann's monosynaptic reflex (H) and direct motor response (M) from the tonic and phasic muscles in drug-induced Parkinson's syndrome Neurologia i Neurochirurgia Polska 4(2): 159-168Christiani, K.; Möller, W.D. 1973: Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor Münchener Medizinische Wochenschrift 115(16): 711-713
Graille, V.; Lapeyre-Mestre, M.; Montastruc, J.L. 1994: Amiodarone-induced pleuropneumopathies: experience 1983-1993 in a drug vigilance Regional Center Therapie 49(5): 421-424
Nishikaze, O. 1975: Drug-drug interaction and drug-induced interference with clinical laboratory test procedures--chairman's introductory remarks Rinsho Byori. Japanese Journal of Clinical Pathology 23(2): 75
Fischer, P.A. 1983: Drug treatment of Parkinson syndrome Die Medizinische Welt 34(7): 220-221
Factor, S.A.; Molho, E.S.; Podskalny, G.D.; Brown, D. 1995: Parkinson's disease: drug-induced psychiatric states Advances in Neurology 65: 115-138
Greene, P.; Cote, L.; Fahn, S. 1993: Treatment of drug-induced psychosis in Parkinson's disease with clozapine Advances in Neurology 60: 703-706
Völler, G.W. 1979: Parkinson syndrome--a contribution on current drug therapy Medizinische Monatsschrift für Pharmazeuten 2(2): 33-40
Lukoshevichiute, A.I.; Reĭngardene, D.I. 1981: Value of drug tests in Wolff-Parkinson-White syndrome Kardiologiia 21(10): 113-116
Friedman, A. 1985: Drug-induced dyskinesia during the treatment of Parkinson disease--biochemical studies Neurologia i Neurochirurgia Polska 19(5): 401-403
Imbs, J.-L.; Welsch, M. 2002: Drug vigilance La Revue du Praticien 52(5): 502-506
Andersson, M.L.; Böttiger, Y.; Lindh, J.D.; Wettermark, B.; Eiermann, B. 2013: Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care European Journal of Clinical Pharmacology 69(3): 565-571
Amerio, P.; Innocente, C.; Feliciani, C.; Angelucci, D.; Gambi, D.; Tulli, A. 2006: Drug-induced cutaneous lupus erythematosus after 5 years of treatment with carbamazepine European journal of dermatology: EJD 16(3): 281-283
Nigen, S.; Knowles, S.R.; Shear, N.H. 2003: Drug eruptions: approaching the diagnosis of drug-induced skin diseases Journal of Drugs in Dermatology: Jdd 2(3): 278-299
Bach, O.; Kästner, I. 1984: Undesired drug side effects and drug-induced damage. II. Centrally acting drugs Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 39(1): 1-6
Koriakin, V.A.; Sokolova, G.B.; Ziia, A.V.; Zeliger, L.R.; Ivleva, A.Ia. 1987: Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients Terapevticheskii Arkhiv 59(7): 75-77
Jennum, P.; Kristensen, M.B. 1985: Drug-induced blood dyscrasias. Reports to the Committee on Adverse Drug Reactions 1968-1983 Ugeskrift for Laeger 147(32): 2539-2541
Kourounakis, P.N.; Rekka, E.; Hadjipetrou-Kourounakis, L. 1991: Restoration of impaired drug metabolism of rats with adjuvant induced disease by two steroids with different influence on drug biotransformation Die Pharmazie 46(10): 727-729
Tohyama, M.; Hashimoto, K. 2007: Drug-induced hypersensitivity syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 341-343
Kuroki, A.; Akizawa, T. 2012: Drug-induced nephrotic syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 6): 419-422